Zydus Life gains over 3% on launch of bladder control drug
Incred Equities estimates Mirabegron to be a $75-80 million opportunity for Zydus Lifesciences, as the company also enjoys a 180-day exclusivity period
Source: moneycontrol.com
Drug Launch News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Drug Launch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Drug Launch Today - Breaking & Trending Today
Zealand becomes a lesson in the rigors of commercialization as a slow launch triggers 90% staff cut, CEO exit
It wasn’t supposed to be this way. Zealand Pharma should be in the honeymoon glow of its first drug launch with a drug approved less than a year ago.
Source: fiercepharma.com
With J&J-partnered CAR-T nod in hand, Legend CEO eyes earlier myeloma use, cheaper cell therapy manufacturing
Nearly five years after unveiling the first clinical data for its BCMA-targeted CAR-T therapy, Legend Biotech has transitioned into a commercial company with an FDA approval for Carvykti and Johnso
Source: fiercepharma.com
Hutchmed unveils new CEO as longtime CSO takes the reins ahead of first U.S. drug launch
Hutchmed’s very first employee and longtime CEO, Chrisian Hogg, is retiring after a 15-year run, just as the Chinese company is prepping to break into the U.S. market.
Source: fiercepharma.com
Novartis says Leqvio launch will feature a 'modest initial ramp,' but blockbuster potential awaits
As Novartis creeps toward losing exclusivity for some big-selling medicines, the drugmaker is counting on new launches to replace lost sales and fuel growth. One such launch is cholesterol drug Leqvio, and execs said Wednesday the company is laying the groundwork for a medicine with "multiblockbuster potential."
Source: fiercepharma.com